ECSP034853A - Composición farmacéutica líquida - Google Patents
Composición farmacéutica líquidaInfo
- Publication number
- ECSP034853A ECSP034853A ECSP034853A ECSP034853A EC SP034853 A ECSP034853 A EC SP034853A EC SP034853 A ECSP034853 A EC SP034853A EC SP034853 A ECSP034853 A EC SP034853A
- Authority
- EC
- Ecuador
- Prior art keywords
- pain
- pharmaceutical composition
- component
- disorders
- compositions
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- HMJIYCCIJYRONP-UHFFFAOYSA-N (+-)-Isradipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC2=NON=C12 HMJIYCCIJYRONP-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 206010006002 Bone pain Diseases 0.000 abstract 1
- 208000014644 Brain disease Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000006083 Hypokinesia Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010038419 Renal colic Diseases 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000003483 hypokinetic effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
- 206010042772 syncope Diseases 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe una composición farmacéutica líquida de un análogo de GABA que comprende al menos un alcohol polihidroxílico que contiene de 2 a 6 átomos de carbono, que tiene un pH desde aproximadamente 5,5 a aproximadamente 7, 0, y además una composición farmacéutica líquida en dos componentes que comprende un primer componente que comprende una mezcla de polvo que comprende un análogo de GABA y un alcohol polihidroxílico sólido, y un segundo componente que comprende una base líquida, así como métodos para preparar las composiciones y un método para tratar enfermedades cerebrales, incluyendo epilepsia, ataques de desfallecimiento, hipoquinesia y traumatismos craneales, trastornos neurodegenerativos, depresión, manía y trastornos bipolares, ansiedad, pánico, inflamación, cólico renal, insomnio, trastornos gastrointestinales, incontinencia, dolor, incluyendo dolor neuropático, dolor muscular, dolor esquelético y migraña, utilizando una cantidad terapéuticamente eficaz de las composiciones farmacéuticas
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29383201P | 2001-05-25 | 2001-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034853A true ECSP034853A (es) | 2003-12-24 |
Family
ID=34699738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034853 ECSP034853A (es) | 2001-05-25 | 2003-11-17 | Composición farmacéutica líquida |
Country Status (5)
| Country | Link |
|---|---|
| EC (1) | ECSP034853A (es) |
| GT (1) | GT200200089A (es) |
| PY (1) | PY0211943A (es) |
| TN (1) | TNSN03125A1 (es) |
| UA (1) | UA75138C2 (es) |
-
2002
- 2002-04-29 UA UA20031110602A patent/UA75138C2/uk unknown
- 2002-05-20 GT GT200200089A patent/GT200200089A/es unknown
- 2002-05-22 PY PY200200211943A patent/PY0211943A/es unknown
-
2003
- 2003-07-08 TN TNPCT/IB2002/001500A patent/TNSN03125A1/fr unknown
- 2003-11-17 EC ECSP034853 patent/ECSP034853A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PY0211943A (es) | 2004-07-01 |
| TNSN03125A1 (fr) | 2005-12-23 |
| UA75138C2 (en) | 2006-03-15 |
| GT200200089A (es) | 2003-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000403A (es) | Composicion farmaceutica liquida | |
| Pei | A review of pharmacology and clinical use of piperine and its derivatives | |
| ATE206305T1 (de) | Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind | |
| UA49011C2 (uk) | Похідні циклічної амінокислоти, фармацевтична композиція та спосіб лікування | |
| EA199800682A1 (ru) | Производные циклической аминокислоты или их фармацевтически приемлемые соли, фармацевтическая композиция и способ лечения депрессии, состояний паники, страха и болевых ощущений | |
| EA200300854A1 (ru) | Применение обратных агонистов гамка в комбинации с частичными агонистами никотиновых рецепторов, эстрогеном, избирательными модуляторами эстрогена или витамином е для лечения познавательных расстройств | |
| WO2005063297A3 (en) | Melatonin combination therapy for improving sleep quality | |
| RU2004110041A (ru) | Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика | |
| ATE353645T1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| SE9501567D0 (sv) | A new combination | |
| ATE277608T1 (de) | 2-arachidonylglycerol, ein hemmer des tumor nekrose faktors -alfa und neuroprotektor des gehirns bei geschlossenen kopfverletzungen | |
| ES2285870T3 (es) | Compuestos 1-(amino ciclico)-alquilciclohexano, composiciones farmaceuticas de los mismos y su uso como anticonvulsivos. | |
| US20160128933A1 (en) | Therapeutic Methods and Compositions | |
| ECSP034853A (es) | Composición farmacéutica líquida | |
| BRPI0509515A (pt) | composto, formulação farmacêutica, uso de um composto método para tratamento de doenças, e, processo para a preparação de um composto | |
| ATE242200T1 (de) | Valnoctamid-stereoisomere, eine methode zu ihrer herstellung und abtrennung und ihre anwendungen | |
| ATE289583T1 (de) | Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen | |
| CN1281222C (zh) | 预防和治疗过早射精和/或性兴奋超敏反应的药物组合物 | |
| UY27310A1 (es) | Composición farmacéutica líquida | |
| DE602006009848D1 (de) | Die regeneration von neuronen des zentralen nervensystems stimulierende peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung | |
| Albanna et al. | Neurological effects of ketamine: mechanisms, addiction potential, and toxicity profiles with focus on Saudi Arabia | |
| RU2139712C1 (ru) | Средство для воздействия на биологически активные точки и рефлексогенные зоны | |
| RS50948B (sr) | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola | |
| BRPI0417797A (pt) | soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos | |
| JP2022510363A (ja) | （ｒ）－２－（２－オキソピロリジン－１－イル）ブタンアミドと（ｓ）－２－（２－オキソピロリジン－１－イル）ブタンアミドを非ラセミ比で含む相乗的組成物 |